1. J. E. Enders. Quality assurance and control, In:
Gennaro A. R. (Eds), Remington: The Science and
Practice of Pharmacy, Vol. I, Lippincott Williams &
Wilkins, New York, 2000, pp. 980-985.
2. http://www.5squalityposters.com/blog/?p=15
accessed on 8/4/2014.
3. L. Lachman, S. A. Hanna and K. Lin. Quality control
and assurance, In: Lachman L, Lieberman H. A,
Kanig J. L. (Eds.), The theory and practice of
industrial pharmacy, Verghese Publishing House,
Bombay, 1976, pp. 804-855.
4. Wikipedia the encyclopedia,
http://en.wikipedia.org/wiki/Quality (business)
accessed on 2/2/2014.
5. Rose and H. Kenneth. Project Quality Management:
Why, What and How, J. Ross Publishing, Fort
Lauderdale, Florida, 2005, pp. 41.
6. http://www.academy-for-leaders.com
/blog/post/61 accessed on 8/4/2014.
7. S. K. Mandal. Introduction to TQM: In TQM,
Principles and practice, Vikas publishing house,
New Delhi, Second reprint, pp. 1-18.
8. A. Lakshmana Rao, M. Bharani, Y. Madhu and G. G.
Sankar. TQM: The Need of New Era, Indian J. Pharm.
Educ. Res. 39(4): 203-206 (2005).
9. Wikipedia the encyclopedia,
http://en.wikipedia.org/wiki/Total_quality_manage
ment accessed on 3/2/2014.
10. Hoyle and David. Quality Management
Essentials, Oxford, United Kingdom: Butterworth-
Heinemann, 2007, pp. 200.
11. Pfeifer and Tilo. Quality Management: Strategies,
Methods, Techniques, Munich, Germany: Carl
Hanser Verlag, 2002, pp. 5.
12. A. L. Rao. TQM: The need of new era, Indian Journal
of Pharmaceutical Education 39(4): 203 (2005).
13. M. Bhaskar, B. Sanjib and Y. Abhishek. TQM in
pharmaceuticals: A review, Int. J. Pharm Tech Res.
3(1): 365-375 (2011).
14. N. Case. Six Sigma Black Belts stamp out tough
quality problems, Quality on line, 1999, available at
http://qualitymag.com/articles/1999/aug99/0899
f3.html accessed on 25/2/2014.
15. http://www.isixsigma.com/new-to-sixsigma/
design-for-six-sigma-dfss/dmaic-versusdmadv/
accessed on 8/2/2014.
16. De Feo, A. Joseph and W. Barnard. Juran institute's
six sigma breakthrough and beyond - quality
performance breakthrough methods, Tata McGraw-
Hill Publishing Company Limited, 2005.
17. J. F. Krafcik. Triumph of the lean production
system, Sloan Management Review, 30 (1): 41–52
(1988).
18. T. Ohno. Toyota Production System, Productivity
Press, 1988, pp. 8.
Ashish et al., ARPB, 2014; Vol 4 (II) ISSN 2250-0774
(REVIEW ARTICLE)
662 | P a g e w w w . a r p b . i n f o
19. J. Womack, D. T. Jones and D. Roos. The machine
that changed the world: the story of lean
production, HarperCollins Publisher, 1990.
20. D. Nave. How to Compare Six Sigma, Lean and the
Theory of Constraints, A framework for choosing
what’s best for your organization, Quality Progress-
March, American society for quality, 2002.
21. E. Griffith. Risk management programs for the
pharmaceutical industry, Fujitsu Consulting, white
paper, Pharmaceutical industry, 2004.
22. “ICH Q9,” 2005. Quality risk management.
23. Wikipedia the encyclopedia,
http://en.wikipedia.org/wiki/Quality_by_Design
accessed on 6/4/2014.
24. “ICH Q8 (R2),” 2009. Pharmaceutical development.
25. S. Kumar and A. Baldi. Design of experiment based
statistical optimization in life science research: An
overview, Pharm Aspire 4: 35-43 (2013).
26. S. Kumar, S. Thakur, D. Tanwar and A. Baldi. A
quantitative approach for pharmaceutical quality by
design patterns, Inventi Rapid: Pharm Analysis &
Quality Assurance 4: 1-8 (2012).
27. Wikipedia the encyclopedia,
http://en.wikipedia.org/wiki/ISO_9000 accessed
on 6/4/2014.
28. http://www.econ.canterbury.ac.nz/downloads/bus
gwp.pdf accessed on 6/4/2014.
29. ISO 9000. Introduction and Support Package:
Guidance on the concept and use of the process
approach for management systems,
http://www.iso.org/iso/04_concept_and_use_of_the
_process_approach_for_management_systems.pdf
accessed on 6/4/2014.
30. Quality management system for active
pharmaceutical ingredients manufacturers
http://apic.cefic.org/pub/2QualityMgtSystGMP971
2.pdf accessed on 6/4/2014.
31. “WHO,” guidelines on good manufacturing practices
for herbal medicines, 2007, available at
http://apps.who.int/medicinedocs/documents/s14
215e/s14215e.pdf accessed on 16/4/2014.
32. http://www.fda.gov/drugs/developmentapprovalp
rocess/manufacturing/ucm090016.html accessed
on 16/4/2014.
33. “Schedule M,” Good manufacturing practices and
requirements of premises, Plant and equipment for
pharmaceutical products, Gazette of india
,Extraordinary, part ii-section 3, sub-section (i),
Ministry of health and family welfare (department
of health) New delhi, 2001, available at
http://www.rajswasthya.nic.in/Drug%20Website%
2021.01.11/Revised%20Schedule%20%20M%204.
pdf accessed on 16/4/2014.
34. J. B. Karmacharya. Good Manufacturing Practices
(GMP) for Medicinal Products, available at
http://cdn.intechopen.com/pdfs-wm/37170.pdf
accessed on 16/4/2014.
35. M. G. De Marinis, M. Piredda, M. C. Pascarella, B.
Vincenzi, F. Spiga, D. Tartaglini, R. Alvaro, M.
Matarese. 'If it is not recorded, it has not been
done!'? consistency between nursing records and
observed nursing care in an Italian hospital, J Clin
Nurs. 19(11-12): 1544-52 (2010).
36. https://www.google.co.in/url?sa=t&rct=j&q=&esr
c=s&source=web&cd=1&cad=rja&ved=0CD8QFjA
A&url=http%3A%2F%2Fwww.fda.gov%2Fohrms
%2Fdockets%2Fac%2F02%2Fbriefing%2F3841b1
_06_astrazeneca.ppt&ei=i0rvUoHPEo6MrgftuIGoCA
&usg=AFQjCNGeecaVZk58yE2nMfWGcPpYXj5OrA&
sig2=j1d0QkUXBhDyXyA6QN7Ww&bvm=bv.6044
4564,d.bmk accessed on 3/2/2014.
37. http://www.brimrose.com/products/nir_mir_spect
rometers.html accessed on 6/3/2014.
38. http://www.piketech.com/files/pdfs/DiffuseAN61
1.pdf accessed on 6/3/2014.
39. http://people.bath.ac.uk/gp304/uv/44-
74668PRD_DiffuseReflectanceTransmittance.pdf
accessed on 6/3/2014.
40. http://www.ciprocess.co.uk/pdfs/CIP%20Introduc
tion.pdf accessed on 6/4/2014.
41. https://www.google.co.in/url?sa=t&rct=j&q=&esr
c=s&source=web&cd=15&cad=rja&uact=8&ved=
0CKkBEBYwDg&url=http%3A%2F%2Fwww.sprin
ger.com%2Fcda%2Fcontent%2Fdocument%2Fcda_
downloaddocument%2F9783319006321-
c2.pdf%3FSG WID %3D0-0-45-1404760-
p175159475&ei=DMMuU8T4E8qZiAeqkoB4&usg=
AFQjCNEqZ78wp65ukXw-_EPunAThyNKRQ&
sig2=kSr7j19YqBF9vIO_aTKEg&bvm=bv.629
22401,d.aGc accessed on 23/03/2014.
42. http://www.aelectric.com/pdfs/takex/Sample_appl
ications.pdf accessed on 23/3/2014.
43. http://www.directindustry.com/prod/datalogicautomation/
miniature-diffuse-reflectionphotoelectric-
sensors-background-suppression-
40572-419014.html accessed on 23/3/2014.
44. http://files.pepperlfuchs.com/selector_files/navi/p
roductInfo/doct/tdoct0799c_eng.pdf accessed on
12/3/2014.
45. A. Bera and A. Mukherjee. The importance of
generic drugs in India, IJPCBS 2(4): 575-587
(2012).
Ashish et al., ARPB, 2014; Vol 4 (II) ISSN 2250-0774
(REVIEW ARTICLE)
663 | P a g e w w w . a r p b . i n f o
46. Y. Ruchir and N. Prajesh. Anticounterfeit packaging
technologies, J Adv Pharm Tech Res. 1(4): 368-373
(2010).
47. D. Y. Magnar and A. Chaudhuri. Counterfeit drugs
problems and solutions for the Indian
pharmaceutical industry, 5: 1-6 (2009).
48. T. K. Mackey and B. A. Liang. The global counterfeit
drug trade: Patient safety and public health risks, J
Pharm Sci. 100: 4571-4579 (2011).
Thank you for copying data from http://www.arastirmax.com
